Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.09 USD | -6.44% | -19.85% | +29.99% |
Apr. 29 | X4 Pharmaceuticals' Xolremdi Approved by FDA For WHIM Syndrome | MT |
Apr. 29 | Transcript : X4 Pharmaceuticals, Inc. - Special Call |
- Stock Market
- Equities
- XFOR Stock
- News X4 Pharmaceuticals, Inc.